多発性内分泌新生病1型では,遺伝子が染色体11にマッピングされ,インスリン腫では失われます
C Larsson1, B Skogseid, K Oberg
1Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden.
Nature
|March 3, 1988
まとめ
多発性内分泌新生病1型 (MEN-1) は遺伝性疾患である. 遺伝学的研究は,MEN-1を染色体11と関連付け,腫瘍発達の過程でマスクを外したリセシブ変異を明らかにした.
科学分野:
- 遺伝学 遺伝学とは
- エンドクリノロジー エンドクリノロジー
- 腫瘍学 腫瘍学
背景:
- 多発性内分泌新生病1型 (MEN-1) は,自己相性優位性遺伝性疾患である.
- MEN-1は,副甲状腺,前垂体,内分泌臓の増殖を引き起こします.
- MEN-1の遺伝的基礎を理解することは,診断と管理に不可欠です.
研究 の 目的:
- MEN-1遺伝子の位置をマッピングする.
- MEN-1腫瘍発生の根底にある遺伝的メカニズムを調査する.
主な方法:
- 家族ベースの遺伝的リンク研究.
- 組織組織と腫瘍組織のゲノタイプ化.
- 人間の筋肉のリン酸化酵素遺伝子を含む遺伝子マーカーの比較.
主要な成果:
- MEN-1の位置は,染色体11にマッピングされた.
- ヒトの筋肉リン酸化酵素遺伝子との密接な関連が実証されました.
- MEN-1における腫瘍発生は,MEN-1ロカスにおけるリセシブ変異のマスクを解明することを含む.
結論:
- MEN-1遺伝子は染色体11に位置しています.
- MEN-1関連腫瘍の発症には2つのヒットメカニズムがあり,後退性突然変異が明らかにされます.
関連する概念動画
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...


